According to research conducted by serialisation system provider SEA Vision and life science technology specialist Zenith Technologies, technology selection is the biggest challenge for companies preparing for serialisation regulations.
Hurdles
The research revealed that 28% of respondents found technology the greatest hurdle while 25% rated understanding the global serialisation requirements as the biggest challenge they face. Tight deployment timescales were highlighted as a major concern by 14% while 12% stated that resourcing deployment of serialisation systems and processes is the most vast barrier to compliance.
Other challenges to attaining compliance highlighted in the research were establishing lifecycle support for systems and selecting an implementation partner, both at 7% each.
“Preparing for serialisation is a complex task and it is clear that the challenges that companies must overcome are wide ranging,” remarked Carlos Machado, serialisation director at SEA Vision US. “Technology selection and implementation is key to project success, and flexibility and scalability are important factors to consider when selecting a serialisation solution that is built for the future.
“Given the multiple technical and logistical challenges associated with implementing a solution, reputable providers should be able to demonstrate a concrete track record of working across varying global serialisation architectures. We expect to see a growing reliance on third party support providers over the coming months as many pharmaceutical manufacturers lack the internal resource and expertise to face the challenge of serialisation head on.”
SEA Vision and Zenith Technologies formed a partnership in 2016 to support pharmaceutical companies with the challenge of integrating and installing serialisation across drug manufacturing sites.